Statistics
Publications
36
Citations
2K
H-Index
25
Active since
2012
Shun Lu is an author at Shanghai Chest Hospital specializing in oncology, medicine, and molecular oncology.
Publications per year
2012–2024
36
36
Amivantamab plus Lazertinib in Previously Untreated <i>EGFR</i> -Mutated Advanced NSCLC
Byoung Chul Cho, Shun Lu, Enriqueta Felip et al. · New England Journal of Medicine · 2024 · 375 citations · Full text
Medicine, Oncology, Pharmacology +14
Desuccinylation of pyruvate kinase M2 by SIRT5 contributes to antioxidant response and tumor growth
Xiangyun Ye, Xiaomin Niu, Gu linping et al. · Oncotarget · 2016 · 166 citations · Full text
Medicine, Cancer Biology, Oncology +17
Martin Reck, Tudor–Eliade Ciuleanu, Manuel Cobo et al. · Journal of Clinical Oncology · 2020 · 152 citations
Medicine, Oncology, Pharmacology +17
Jonathan Spicer, Changli Wang, Fumihiro Tanaka et al. · Journal of Clinical Oncology · 2021 · 137 citations
The Hippo/YAP1 pathway interacts with FGFR1 signaling to maintain stemness in lung cancer
Tingting Lü, Ziming Li, Ying Yang et al. · Cancer Letters · 2018 · 89 citations
1–5 of 36